← Back to Search

Amoxicillin for Penicillin Allergy

Phase 4
Waitlist Available
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10-14 months after amoxicillin challenge
Awards & highlights

Study Summary

This trial is looking at the feasibility of delabeling patients who have a reported penicillin allergy in a pediatric primary care clinic.

Eligible Conditions
  • Penicillin Allergy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10-14 months after amoxicillin challenge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10-14 months after amoxicillin challenge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Subjects stratified as low-risk with a negative immediate amoxicillin challenge in the pediatric primary care setting
Subjects who complete risk-stratification of penicillin allergy in the pediatric primary care setting
Secondary outcome measures
Penicillin allergy labeling in subjects with negative amoxicillin challenge

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pediatric Patients with a history of penicillin allergyExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Amoxicillin
2017
Completed Phase 4
~7780

Find a Location

Who is running the clinical trial?

American College of Allergy, Asthma and ImmunologyOTHER
3 Previous Clinical Trials
31 Total Patients Enrolled
University of Texas Southwestern Medical CenterLead Sponsor
1,047 Previous Clinical Trials
1,053,776 Total Patients Enrolled

Media Library

Amoxicillin Clinical Trial Eligibility Overview. Trial Name: NCT05010304 — Phase 4
Penicillin Allergy Research Study Groups: Pediatric Patients with a history of penicillin allergy
Penicillin Allergy Clinical Trial 2023: Amoxicillin Highlights & Side Effects. Trial Name: NCT05010304 — Phase 4
Amoxicillin 2023 Treatment Timeline for Medical Study. Trial Name: NCT05010304 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical trial accommodate persons of a younger age?

"Based on the requirements listed for participation in this clinical trial, potential candidates must between the ages of 2 and 18. There are 97 studies that cater to younger patients while 202 focus on those above 65 years old."

Answered by AI

Does my profile qualify me to participate in this research experiment?

"This trial requires 200 participants with a documented penicillin allergy, aged 2 to 18. Notably, the eligibility criteria specifies that children must have had parent-reported hypersensitivity in order to be considered."

Answered by AI

Has Amoxicillin undergone the FDA's evaluation process?

"Our experts at Power rate Amoxicillin's safety a 3, as it has passed through Phase 4 and is approved for medical use."

Answered by AI

In what contexts is Amoxicillin regularly prescribed?

"Amoxicillin has demonstrated efficacy for treating lower respiratory tract infection (lrti) and is historically used to manage bacterial infections, endocarditis, as well as fusospirochetosis."

Answered by AI

To what extent is this experiment being conducted with human participants?

"Affirmative. Clinicaltrials.gov data shows that this clinical trial, which was initially posted on December 9th 2021, is still in search of participants. 200 subjects need to be enrolled from 1 site for the study's completion."

Answered by AI

Is this research endeavor currently looking for new participants?

"The current clinical trial status, as evident in the clinicaltrials.gov database, is actively recruiting participants. The study was initially made available on December 9th 2021 and its details were most recently revised on December 1st 2022."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Penicillin De-labeling in the Pediatric Primary Care Setting
Timothy Chow 2021. "Penicillin De-labeling in the Pediatric Primary Care Setting". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05010304.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top